1. Pharmacokinetics and Pharmacodynamics of Imipenem and Meropenem in Critically Ill Patients Treated With Continuous Venovenous Hemodialysis 
David Afshartous, PhD, Seth R. Bauer, PharmD, Michael J. Connor, MD, Olufemi A. Aduroja, MD, Milen Amde, MD, Charbel Salem, MD, Joseph J. Groszek, William H. Fissell, MD 
American Journal of Kidney Diseases 
Volume 63, Issue 1, Pages (January 2014)
DOI: /j.ajkd
Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Distribution of fractional time plasma concentration was >8 μg/mL (4×MIC for susceptible bacteria). Drug exposure as estimated by this metric varied widely between individuals.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions